CD8A and COVID-19: SARS-CoV-2-specific CD8+ T cell responses have been detected in the acute and convalescent phases of COVID-19 [132,133,134,135,136,137], and CD8+ T cells have been found to contribute to protection from the development of severe COVID-19 in animals experimentally infected with SARS-CoV-2 [138,139].